Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain.
Hum Vaccin Immunother
; 17(3): 654-655, 2021 03 04.
Article
in English
| MEDLINE | ID: covidwho-801647
ABSTRACT
A safe and effective vaccine candidate is urgently needed for the ongoing COVID-19 pandemic, caused by SARS-CoV-2. Here we report that recombinant SARS-CoV-2 RBD protein immunization in mice is able to elicit a strong antibody response and potent neutralizing capability as measured using live or pseudotyped SARS-CoV-2 neutralization assays.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Protein Binding
/
Antibodies, Neutralizing
/
Protein Domains
/
SARS-CoV-2
/
COVID-19
/
Antibodies, Viral
Topics:
Vaccines
Limits:
Animals
/
Humans
Language:
English
Journal:
Hum Vaccin Immunother
Year:
2021
Document Type:
Article
Affiliation country:
21645515.2020.1814098
Similar
MEDLINE
...
LILACS
LIS